U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Clinical Guideline Centre (UK). Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease. London: Royal College of Physicians (UK); 2012 Aug. (NICE Clinical Guidelines, No. 148.)

Cover of Urinary Incontinence in Neurological Disease

Urinary Incontinence in Neurological Disease: Management of Lower Urinary Tract Dysfunction in Neurological Disease.

Show details

Appendix KExcluded studies

K.1. Does the use of clinical assessment, urine culture, a residual urine estimate or a bladder diary/frequency volume chart change the management of patients with neurological disease?

K.1.1. Clinical Studies excluded

K.1.2. Economic Studies excluded

K.2. Does the use of the urodynamics (filling cystometry, leak point pressure measurements, pressure-flow studies of voiding, video urodynamics) direct treatment or stratify risk of renal complications (such as hydronephrosis)

K.2.1. Clinical studies excluded

K.2.2. Economic studies excluded

K.3. Does provision of information and support regarding the different management systems improve patient outcomes?

K.3.1. Clinical studies excluded

K.3.2. Economic studies excluded

K.4. Do behavioural management programmes (timed voiding, voiding on request, prompted voiding, bladder retraining, habit retraining, urotherapy) compared with a) each other b) usual care, improve outcomes?

K.4.1. Clinical studies excluded

K.4.2. Economic studies excluded

K.5. What is the safety and efficacy of antimuscarincs compared with a) placebo or treatment as usual b) other antimuscarinics for the treatment of incontinence due to neurological disease/overactive bladder due to neurological disease?

K.5.1. Clinical studies excluded

K.5.2. Economic Studies excluded

K.6. What is the safety and efficacy of detrusor injections of botulinum toxin type A or B compared with a) usual care b) antimuscarinics in neurological disease?

K.6.1. Clinical studies excluded

K.6.2. Economic studies excluded

K.7. What is the safety and efficacy of augmentation cystoplasty compared with a) Botulinum toxin b) usual care in neurological disease c) urinary diversion?

K.7.1. Clinical studies excluded

K.7.2. Economic studies excluded

K.8. Does pelvic floor muscle training with or without electrical stimulation or biofeedback compared with treatment as usual, improve outcomes?

K.8.1. Clinical studies excluded

K.8.2. Economic studies excluded

K.9. What is the safety and efficacy of urethral tape and sling surgery compared with a) bladder neck closure b) usual care in neurological disease?

K.9.1. Clinical studies excluded

K.9.2. Economic studies excluded

K.10. What is the safety and efficacy of artificial urinary sphincter compared with other treatments in neurological disease?

K.10.1. Clinical studies excluded

K.10.2. Economic studies excluded

K.11. What is the safety and efficacy of alpha adrenergic antagonists compared with a) other adrenergic antagonists b) placebo/usual care for the treatment of incontinence due to neurological disease?

K.11.1. Clinical studies excluded

K.11.2. Economic studies excluded

K.12. What is the safety and efficacy of the catheter valve compared with urinary drainage bags in neurological disease?

No papers were ordered for this question

K.13. What is the efficacy of the ileal conduit diversion compared with usual care in neurological disease?

K.13.1. Clinical studies excluded

K.13.2. Economic studies excluded

K.14. Do prophylactic antibiotics compared with a) no treatment b) other antibiotics reduce the risk of symptomatic urinary tract infections?

K.14.1. Clinical evidence excluded

K.14.2. Economic evidence excluded

K.15. Does monitoring or do surveillance protocols improve patient outcomes?

K.15.1. Clinical studies included

K.15.2. Economic studies excluded

K.16. What are the long term risks associated with the long term use of intermittent catheterisation, indwelling catheters and penile sheaths?

K.16.1. Clinical studies excluded

K.16.2. Economic studies excluded

K.17. For patients and their carers with lower urinary tract dysfunction associated with neurological disorders, what are the experiences of access to and interaction with services that address these issues?

K.17.1. Clinical studies excluded

K.17.2. Economic studies excluded

K.18. What interventions or configuration of services improve outcomes when a patient is transferred from child to adult services?

K.18.1. Clinical studies excluded

K.18.2. Economic studies excluded

K.19. What criteria or signs/symptoms should be used to refer patients for specialist assessment?

No search conducted

Copyright © 2012, National Clinical Guideline Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

Bookshelf ID: NBK132822

Views

In this Page

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...